STOCK TITAN

RVL Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

RVL Pharmaceuticals plc (Nasdaq: RVLP), a specialty pharmaceutical company, announced its participation in the Barclays Global Healthcare Conference 2022. Key executives, including CEO Brian Markison, COO James Schaub, and CFO Andrew Einhorn, will present on March 16, 2022, at 11:15 a.m. ET. The presentation will be available via a webcast, accessible on the company’s website afterward. RVL focuses on developing products for underserved patient populations, with a subsidiary dedicated to ophthalmic and medical aesthetics.

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

BRIDGEWATER, N.J., March 09, 2022 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company, announced today that Brian Markison, Chief Executive Officer, James “JD” Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will present at the Barclays Global Healthcare Conference 2022, as follows:

Date:
Time:
Webcast:
Wednesday, March 16, 2022
11:15 a.m. ET
https://cc.webcasts.com/barc002/031522a_js/?entity=85_1GFQ11B
  

The webcast will be available thereafter via the Company’s website www.rvlpharma.com website under the “Investor & News” section.

About RVL Pharmaceuticals plc
RVL Pharmaceuticals plc (Nasdaq: RVLP) is a specialty pharmaceutical company focused on the development and commercialization of products that target markets with underserved patient populations. RVL Pharmaceuticals, Inc., is the Company’s ophthalmic and medical aesthetics subsidiary supporting UPNEEQ®.

Investor and Media Relations for RVL Pharmaceuticals plc
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com


FAQ

When will RVL Pharmaceuticals present at the Barclays Global Healthcare Conference 2022?

RVL Pharmaceuticals will present on March 16, 2022, at 11:15 a.m. ET.

Who are the executives presenting for RVL Pharmaceuticals at the conference?

The executives presenting are CEO Brian Markison, COO James Schaub, and CFO Andrew Einhorn.

Where can I find the webcast for RVL Pharmaceuticals' presentation?

The webcast will be available through the company's website at www.rvlpharma.com.

What is the focus of RVL Pharmaceuticals?

RVL Pharmaceuticals focuses on developing and commercializing products for underserved patient populations.

What is RVL Pharmaceuticals' stock symbol?

RVL Pharmaceuticals is listed under the stock symbol RVLP.
RVL Pharmaceuticals plc

NASDAQ:RVLP

RVLP Rankings

RVLP Latest News

RVLP Stock Data

3.14M
55.99M
27.01%
49.1%
2.94%
Biotechnology
Healthcare
Link
United States
Bridgewater